Skip links

Annual Immuno-Oncology Summit, October 12–14, 2022, Boston, MA, US

Our CSO, Michael Thiele will attend the 10th Annual Immuno-Oncology Summit in Boston. Michael will give a talk on immunomodulatory activities of our clinical candidate anti-oxMIF antibody ON203 in patient-derived colorectal cancer tumoroids.

Home